In this context, CKD patients often exhibit markedly elevated circulating SAA levels [26, 65, 71, 142], and a recent meta-analysis demonstrated a positive, linear association between SAA levels and the risks of all-cause and cardiovascular mortality in this population [93]. This evidence concerns the gene SAA2 and chronic kidney disease.